- •Series Editors
- •Contributors
- •Preface
- •Previous Volumes in Series
- •Relationship of Solute and Water Secretion
- •Centrality of NaCl Secretion
- •Transcellular and Paracellular Components of Secretion
- •Uptake of Stromal NaCl
- •Passage of NaCl from PE to NPE Cells Through Gap Junctions
- •Extrusion of NaCl from NPE Cells to Aqueous Humor
- •Transfer of Water from Stroma to Aqueous Humor
- •Potential Unidirectional Reabsorption of Aqueous Humor
- •Transport Components Underlying Potential Transcellular Reabsorption Across the Ciliary Epithelium
- •References
- •References
- •The Role of Gap Junction Channels in the Ciliary Body Secretory Epithelium
- •Overview
- •General Properties of Connexins Including those Composing the Ciliary Body Epithelium Gap Junctions
- •Animal Models Support a Role for Gap Junctions in Fluid Transport by Ocular Epithelia
- •References
- •Relationship of the EMPA Findings to the Consensus Model for Aqueous Humor Secretion
- •References
- •Functional Modulators Linking Inflow with Outflow of Aqueous Humor
- •Overview
- •Sources of Neuropeptides and Peptide Hormones in the AqH
- •Expression in the Human CB of Glutamate Transporters of the Excitatory Amino Acid Transporters Family
- •Potential Neuroendocrine Entrainment of Circadian Rhythms: AqH Secretion and IOP
- •References
- •Aqueous Humor Outflow Resistance
- •References
- •Aqueous Humor Dynamics I
- •Measurement Methods and Animal Studies
- •Overview
- •Components of Aqueous Humor Dynamics and Measurement Techniques
- •Tonometry
- •Manometry
- •Telemetry
- •Fluorophotometry
- •Confocal Microscopy
- •Aqueous Humor Sampling Method
- •Tonography
- •Fluorophotometry
- •Perfusion Methods
- •Mathematical Calculation
- •Intracameral Tracer Methods
- •Episcleral Venomanometry
- •Direct Cannulation
- •Intracameral Microneedle Method
- •Acknowledgment
- •References
- •Aqueous Humor Dynamics II
- •Dopaminergic Agonists and Antagonists
- •Regulators of the Actin Cytoskeleton
- •Serotonin Agonists
- •References
- •Effects of Circulatory Events on Aqueous Humor Inflow and Intraocular Pressure
- •References
- •Overview
- •Nitric Oxide
- •Glutamate
- •Purines
- •References
- •What is Functional Genomics Teaching us about Intraocular Pressure Regulation and Glaucoma?
- •Functional Genomics: Microarrays, Proteomics and Protein Modification
- •The Trabecular Meshwork Tissue: Expressed Genes (CDNA) and Proteins Obtained by Direct Sequencing and Mass Spectrometry
- •References
- •Molecular Approaches to Glaucoma: Intriguing Clues for Pathology
- •References
- •Outflow Signaling Mechanisms and New Therapeutic Strategies for the Control of Intraocular Pressure
- •Trabecular Pathway
- •Uveoscleral Pathway
- •Carbonic Anhydrase Inhibitors
- •Cholinergics
- •Epinephrine and Analogs
- •Prostaglandin Analogs
- •Cytochalasins
- •Latrunculins
- •Swinholide A
- •Ethacrynic Acid
- •Protein Kinase Inhibitors
- •Broad Spectrum Kinase Inhibitors
- •ROCK Inhibitors
- •CTGF
- •Cochlin
- •References
- •Index
194 |
Toris |
aqueous humor dynamics include aqueous flow, outflow facility, uveoscleral outflow, and episcleral venous pressure. Multiple methods are available to assess these components. Interpretation of data collected by these methods requires an understanding of the inherent assumptions and limitations of each method applicable to the species of animal under investigation. Despite the inevitable problems associated with each method, invaluable information has been collected regarding normal circadian rhythms and interspecies diVerences in aqueous humor dynamics. Additionally, studies of animal models of spontaneous and induced glaucoma have enhanced our understanding of human glaucoma and facilitated the design of improved pharmacological treatments and surgical procedures. This chapter describes the various methods to assess aqueous humor dynamics and summarizes findings from the animal species that have contributed the most to our understand of aqueous humor dynamics.
II.COMPONENTS OF AQUEOUS HUMOR DYNAMICS AND MEASUREMENT TECHNIQUES
The major components of aqueous humor dynamics include the production rate of aqueous humor, resistance to outflow through the trabecular meshwork, rate of outflow from the anterior chamber angle other than through the trabecular meshwork (most commonly termed uveoscleral outflow, although other descriptive names exist), and the pressure in the aqueous humor collection vessels (episcleral venous pressure).
The original Goldmann equation described the relationship between the IOP and the components of aqueous humor dynamics as they were understood half a century ago:
Fp |
þ Pv |
ð1Þ |
IOP ¼ Ctrab |
where IOP is intraocular pressure, Fp is the rate of aqueous humor production and drainage, Ctrab is the facility of outflow through the trabecular meshwork, and Pv is the pressure in the vessels that drain the aqueous humor from the trabecular meshwork (episcleral veins). In the early studies describing the relationship between IOP and components of aqueous humor dynamics, it was believed that the aqueous humor secreted by the ciliary processes entered the anterior chamber and drained exclusively through the trabecular meshwork. Tracer originally injected into the anterior chamber that was occasionally observed in the uvea was thought to be inconsequential. Since the original equation was written, the importance of
7. Aqueous Humor Dynamics I |
195 |
uveoscleral outflow has become more apparent and the Goldmann equation was changed accordingly. In a steady state, aqueous humor production (Fp) is the sum of aqueous humor drainage through the two outflow pathways: trabecular (Ftrab) and uveoscleral (Fu).
Fp ¼ Fu þ Ftrab |
ð2Þ |
Ftrab is pressure dependent, that is, as IOP increases, fluid flow through the trabecular meshwork increases. Ftrab can be rewritten as the product
of the facility of trabecular outflow (Ctrab) and the pressure diVerence across the trabecular meshwork (IOP Pv). Hence, trabecular outflow is described as given below:
Ftrab ¼ CtrabðIOP PvÞ |
ð3Þ |
Subs titution ofEq. (3)into Eq. (2)yiel ds:
Fp ¼ Fu þ CtrabðIOP PvÞ |
ð4Þ |
Assessment of aqueous humor dynamics requires the evaluation of each of these variables. Studies of aqueous humor dynamics in mice, rats, rabbits, cats, dogs, and monkeys are summarized in Tables I through VI. Clinical studies of aqueous humor dynamics are described in Chapter 8.
A. Intraocular Pressure
The health of the eye and normal visual function require a firm control of the IOP. When the IOP deviates from a narrow healthy range for an extended period of time, irreversible damage may occur to the optic nerve and retina, resulting in permanent vision loss. Transient changes in the IOP occur by seemingly benign daily activities including blinking, wearing a tight necktie, stooping, a valsalva maneuver, or a bowel movement. Eyelid pressure, tension on extraocular muscles, arterial and venous blood pressure, and gravity are additional factors that aVect the IOP. Intraocular pressure under steady state conditions occurs at a time when aqueous humor inflow and outflow are equal and the pressure in the eye is relatively stable. Normal values of steady state IOP in research animals are surprisingly similar among species, 15–17 mmHg in mice and rats (Tables I and II), 10–25 mmHg in rabbits (Table III), 14–25 mmHg in cats (Table IV), 9–26 mmHg in dogs (Table V), and 14–23 mmHg in monkeys (Table VI). Acute measurements of the IOP are made indirectly by tonometry and directly by manometry. Continuous IOP measurements over a period of weeks to months are made by telemetry.
196 |
|
|
|
|
|
|
Toris |
|
|
|
|
TABLE I |
|
|
|
|
|
|
|
Aqueous Humor Dynamics in Mice |
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
C (ml/ |
|
|
|
|
|
|
IOP |
|
min/ |
Pev |
Fu(ml/ |
|
Reference |
Animal |
Anesthesia |
(mmHg) |
Fa (ml/min) |
mmHg) (mmHg) |
min) |
|
|
|
|
|
|
|
|
|
|
|
Fan et al., |
CD1 |
Ketamine |
|
0.09 0.01a |
|
|
|
|
2007 |
|
xylazine |
|
|
|
|
|
|
|
|
Avertind |
|
0.20 0.03a |
|
|
|
|
Crowston |
Swiss |
Ketamine |
15.7 1.0 |
0.14 0.04b |
0.0053 |
|
0.115 |
|
et al., 2004 |
white |
xylazine |
|
|
0.0014 |
|
|
|
Aihara et al., |
Swiss |
Ketamine |
15.7 2.0 |
0.18 0.05b |
0.0051 |
9.5 1.2 |
0.148 |
|
2003a |
white |
xylazine |
|
|
0.0006 |
|
|
|
Aihara et al., |
Swiss |
Ketamine |
16.5 0.6 |
|
|
9.6 1.3 |
|
|
2003b |
white |
xylazine |
|
|
|
|
|
|
Zhang et al., |
CD1 |
Ketamine |
16.0 0.4 |
0.06 0.03c |
0.006 |
|
|
|
2002 |
|
|
|
|
0.001 |
|
|
|
|
|
|
|
|
|
|
|
|
Reported are mean values from untreated or vehicle treated control groups standard errors or standard deviations as provided in the original papers.
C, outflow facility measured by two level constant pressure perfusion method; Fa, aqueous flow measured by afluorophotometry, baqueous humor sampling method, cconfocal microscopy; Fu, uveoscleral outflow calculated from the modified Goldmann equation; IOP, intraocular pressure measured by manometry; Pev, episcleral venous pressure measured by the intracameral microneedle method, d2,2,2 tribromoethanol.
TABLE II
Aqueous Humor Dynamics in Rats
|
|
|
|
Fa |
C (ml/min/ |
References |
Animal |
Anesthesia |
IOP (mmHg) |
(ml/min) |
mmHg) |
|
|
|
|
|
|
Nguyen |
Sprague |
Ketamine |
15.5 0.29a |
|
0.034 0.001 |
et al., 2007 |
Dawley |
xylazine |
|
|
|
Kee, Hong and |
Sprague |
Sodium |
|
|
0.051 0.004 |
Choi, 1997 |
Dawley |
pentobarbital |
|
|
|
Kee and |
Sprague |
Sodium |
|
|
0.040 0.004 |
Seo, 1997 |
Dawley |
pentobarbital |
|
|
|
Mermoud |
Lewis rats |
Ketamine |
17.2 1.8b |
0.35 0.11 |
0.044 0.015 |
et al., 1996 |
|
xylazine |
|
|
|
|
|
|
|
|
|
Reported are mean values from untreated or vehicle treated control groups standard errors or standard deviations as provided in the original papers.
C, outflow facility measured by the two level constant pressure perfusion method; Fa, aqueous flow measured by the aqueous humor sampling method; IOP, intraocular pressure measured by aTono Pen, bmanometry.
TABLE III
Recent Studies of Aqueous Humor Dynamics in Rabbits
|
|
|
IOP |
Fa (ml/ |
C (ml/min/ |
|
Pev |
References |
Animal |
Treatments |
(mmHg) |
min) |
mmHg) |
Fu (ml/min) |
(mmHg) |
|
|
|
|
|
|
|
|
Ocular normotensive rabbits |
|
|
|
|
|
|
|
Kiel and Reitsamer, 2007 |
New Zealand |
Pentobarbital |
18.9 1.3 |
3.3 0.2d |
|
|
|
|
white |
|
|
|
|
|
|
Oka et al., 2006 |
Japanese albino |
Vehicle |
17–18 |
2.8 0.4d |
0.15 0.02b |
0.53 0.05f |
|
Toris, Zhan and |
Dutch belted |
Vehicle |
23.7 2.2 |
2.7 0.6d |
|
|
|
McLaughlin, 2003 |
|
|
|
|
|
|
|
Kotikoski, Vapaatalo |
New Zealand |
Ketamine/xylazine |
10–12 |
|
0.45–0.75b |
|
|
and Oksala, 2003 |
white |
indomethacin |
|
|
|
|
|
Wang et al., 2003 |
Rabbit |
Saline |
|
|
|
0.18 0.05f |
|
Zhan et al., 2002 |
New Zealand |
None |
20.1 1.5 |
2.8 0.2d |
|
0.32 0.03f |
|
|
white |
|
|
|
|
|
|
|
|
None |
21.7 0.9 |
2.5 0.2d |
0.24 0.03a |
|
|
|
|
None |
17.2 0.9 |
1.7 0.2d |
0.21 0.01a |
0.37 0.06f |
|
Reitsamer and Kiel, |
New Zealand |
Pentobarbital |
15.8 0.8 |
|
|
|
9.6 0.9 |
2002 |
white |
|
|
|
|
|
|
|
|
|
16.4 1.1 |
|
|
|
|
|
|
|
17.2 1.2 |
2.9 0.4e |
0.38 0.05a |
|
|
Puras et al., 2002a |
New Zealand |
Vehicle |
20.7 0.7 |
|
|
||
|
white |
|
|
|
|
|
|
(Continued)
197
198
|
|
TABLE III |
(Continued) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
IOP |
Fa (ml/ |
C (ml/min/ |
|
Pev |
References |
Animal |
Treatments |
(mmHg) |
min) |
mmHg) |
Fu (ml/min) |
(mmHg) |
|
|
|
|
|
|
|
|
Chu and Potter, 2002 |
New Zealand |
None |
21.0 1.5 |
2.3 0.3d |
|
|
|
|
white |
|
|
|
|
|
|
Ogidigben and Potter, |
New Zealand |
None |
25.5 |
2.3 0.6d |
|
|
|
2001 |
white |
|
|
|
|
|
|
Chidlow et al., 2001 |
New Zealand |
None |
17.2 0.3 |
|
0.15 0.01b |
|
|
|
white |
|
|
|
|
|
|
Inoue et al., 2001 |
New Zealand |
Saline |
|
|
0.29 0.08b |
1.84 0.07f |
|
|
white |
|
|
|
|
|
|
Kiel et al., 2001 |
New Zealand |
Pentobarbital |
15.8 1.2 |
2.8 0.2d |
|
|
|
|
white |
|
|
|
|
|
|
|
|
|
15.7 1.1 |
3.1 0.4d |
0.21 0.03b |
0.42 0.04f |
|
Sugiyama et al., 2001 |
Japanese white |
None |
14–17 |
|
|
||
Honjo et al., 2001 |
Japanese white |
None |
|
|
0.12 0.01b |
0.47 0.03f |
|
Crosson, 2001 |
New Zealand |
Vehicle |
|
2.0 0.3d |
0.22 0.02c |
|
|
|
white |
|
|
|
|
|
|
Russell, Wang and |
New Zealand |
None |
25–26 |
2.4–3.3d |
|
|
|
Potter, 2000 |
white |
|
|
|
|
|
|
Muta et al., 2000 |
Albino |
None |
26.0 1.3 |
2.7 0.3d |
0.22 0.06c |
0.04 0.42g |
|
Melena et al., 1999 |
New Zealand |
None |
20.1 0.8 |
3.1 0.2e |
0.24 0.01a |
|
|
|
white |
|
|
|
|
|
|
Crosson and Petrovich, |
New Zealand |
Vehicle |
|
|
0.23 0.01b |
|
|
1999 |
white |
|
|
|
|
|
|
Artru and Momota, 1999 |
New Zealand |
Sevoflurane |
13 |
3 |
4.0 1.0e |
0.24 0.13b |
0.5 |
0.1g |
|
white |
|
|
|
|
|
|
|
Kanno et al., 1998 |
New Zealand |
Vehicle |
|
|
2.9 0.1d |
0.19 0.01c |
0.16 |
0.01f |
|
white |
|
|
|
|
|
|
|
Zhan et al., 1998 |
New Zealand |
Vehicle |
19.4 |
1.3 |
2.6 0.1d |
0.25 0.03b |
0.31 |
0.09f |
|
white |
|
|
|
|
|
|
|
Ocular hypertensive rabbits (a chymotrypsin model)
Puras et al., 2002b |
New Zealand |
a-chymotrypsin |
35.0 0.9 |
4.9 1.0e |
0.25 0.04a |
|
white |
|
|
|
|
Melena et al., 1999 |
New Zealand |
a-chymotrypsin |
39.3 2.5 |
5.4 0.6e |
0.21 0.02a |
|
white |
|
|
|
|
|
|
|
|
|
|
Values are means standard error or standard deviation as provided in the original paper. The selected articles are those published within the past decade that reported one or mores value of aqueous humor dynamics in untreated or vehicle treated ocular normotensive or hypertensive rabbits.
C, outflow facility measured by atonography, btwo level constant pressure perfusion method, cflow to blood method; Fa, aqueous flow measured by dfluorophotometry, ecalculation; Fu, uveoscleral outflow measured by fintracameral tracer method, gmathematical calculation; IOP, intraocular pressure measured by pneumatonometry.
199
200
TABLE IV
Aqueous Humor Dynamics in Cats
References |
Anesthesia |
IOP (mmHg) |
|
Fa (ml/min) |
C (ml/min/mmHg) |
Fu (ml/min) Pev (mmHg) |
|||||
|
|
|
|
|
|
|
|
|
|
|
|
Hayashi, Yablonski |
Ketamine xylazine (n ¼ 15) |
17 |
0.8 |
4.4 |
0.5d |
1.37 |
0.34a |
|
12.0 0.8 |
||
and Bito, 1987 |
|
16 |
2.3 |
3.5 |
0.4 |
d |
1.14 |
a |
|
13.6 0.8 |
|
|
|
|
0.11 |
|
|||||||
Goh, Oshima and Araie, 1994 |
Ketamine (n ¼ 10) |
24.5 |
1.1 |
12.1 |
2.9d |
0.48 |
0.12a |
0.88 |
0.07f |
||
|
|
23.0 |
1.3 |
12.4 |
1.1d |
|
|
1.13 |
0.25f |
||
Toris et al., 1995 |
Ketamine (n ¼ 12) |
14.0 |
3.5 |
6.0 |
1.4d |
0.48 |
0.36b |
2.1 |
2.2g |
||
|
|
|
|
|
|
|
|
|
|
1.5 |
0.6f |
Wang et al., 1999 |
Ketamine (n ¼ 10–12) |
22.2 |
1.2 |
6.0 |
0.3d |
0.26 |
0.04b |
2.98 |
0.58g |
||
Higginbotham et al., 1988 |
Ketamine acepromazine (n ¼ 4) |
22.8 |
11.4 |
6.6 |
3.3d |
0.27 |
0.02a |
1.42 |
0.48f |
||
|
|
|
|
||||||||
|
Ketamine xylazine |
23.0 |
11.5 |
6.4 |
3.2d |
|
|
|
|
||
Rosenberg et al., 1996 |
24.6 |
3.1 |
4.0 |
1.8e |
0.25a |
|
|
8 |
|||
Oksala and Stjernschantz, 1988 |
Ketamine xylazine |
16.7 |
1.6 |
|
|
|
|
0.74 |
0.22b |
|
|
Colasanti, 1990 |
Sodium pentobarbital |
21.9 |
1.0 |
10.6 |
2.4c |
0.98 |
0.06b |
|
|
||
|
|
24.2 |
0.6 |
12.5 |
2.4c |
0.87 |
0.10b |
|
|
||
|
|
|
|
8.25 |
0.6c |
0.70 |
0.14b |
|
|
||
Values are means standard error or standard deviation (when available) as provided in original publications. The selected articles are those published since 1980 that reported one or more values of aqueous humor dynamics in healthy untreated or vehicle treated cats.
C, outflow facility measured by atonography, btwo level constant pressure perfusion method; Fa, aqueous flow measured by can aqueous humor sampling method, dfluorophotometry, emathematical calculation; Fu, uveoscleral outflow measured by fintracameral tracer method, gmathematical calculation; IOP, intraocular pressure measured by pneumatonometry; Pev, episcleral venous pressure measured by venomanometry.
TABLE V
Aqueous Humor Dynamics in Dogs
|
|
|
|
|
Fa (ml/ |
C (ml/min/ |
Pev |
References |
Animal |
Anesthesia |
IOP (mmHg) |
min) |
mmHg |
(mmHg) |
|
|
|
|
|
|
|
|
|
Ocular normotensive dogs |
|
|
|
|
|
|
|
Toris et al., 2006a |
Normal beagles (4) |
Butorphenol |
12.8 |
2.1 |
6.8 2.4 |
|
|
Skorobohach, |
Normal beagles (5) |
Tiletamine zolazepam, |
14–17 diurnal |
5.1 2.0 |
|
|
|
Ward |
|
butorphanol |
range |
|
|
|
|
and Hendrix, |
|
|
|
|
|
|
|
2003 |
|
|
|
|
|
|
|
Ward et al., 2001 |
Normal beagles (15) |
Tiletamine zolazepam, |
|
|
5.2 1.9 |
|
|
|
|
butorphanol |
|
|
|
|
|
Cawrse, Ward and |
Normal beagles (15) |
Tiletamine zolazepam, |
16–18 diurnal |
5.9 |
|
|
|
Hendrix, 2001 |
|
butorphanol |
range |
|
|
|
|
Kurata et al., 1998 |
Normal beagles (6) |
Not reported |
17.7–19.0 |
|
0.23–0.28a |
|
|
Artru, 1995 |
Mongrel dogs (10–12) |
Desflurane |
11.3 |
3.8 |
1.6 0.6 0.097 0.062a |
|
|
|
|
Halothane |
9.4 |
2.8 |
1.5 0.5 0.091 0.054a |
|
|
Gelatt et al., 1982 |
Normal beagles (6) |
Acepromazine ketamine |
23.4 |
1.5 |
|
|
11.7 0.3 |
|
|
Thiamylal sodium |
19.9 |
0.6 |
|
|
11.6 0.4 |
|
|
Halothane |
|
|
|
|
|
PeiVer et al., 1980 |
|
Ketamine xylazine |
26.0 |
2.1 |
|
0.22 0.03a |
11.4 0.7 |
Normal beagles (18) |
Sodium pentobarbital |
|
|
|
|
||
Gelatt et al., 1977 |
Normal beagles (37) |
Acepromazine ketamine |
|
|
|
0.24 0.07b |
|
(Continued)
201
202
|
|
TABLE V |
(Continued) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fa (ml/ |
C (ml/min/ |
Pev |
References |
Animal |
Anesthesia |
IOP (mmHg) |
min) |
mmHg |
(mmHg) |
|
|
|
|
|
|
|
PeiVer et al., 1976 |
Normal beagles (36) |
Sodium pentobarbital |
|
|
0.21 0.14b |
|
|
|
Ketamine acetyl promazine |
|
|
|
|
Glaucomatous dogs |
|
|
|
|
|
|
Gelatt et al., 1982 |
Glaucomatous beagles |
Acepromazine ketamine |
34.2 3.7 |
|
|
10.6 0.3 |
|
(12) |
|
|
|
|
|
|
|
Thiamylal sodium |
27.4 0.4 |
|
|
12.1 0.4 |
|
|
Halothane |
|
|
|
|
PeiVer et al., 1980 |
|
Ketamine xylazine |
37.8 4.2 |
|
0.09 0.01a |
12.5 0.5 |
Glaucomatous beagles |
Sodium pentobarbital |
|
|
|
||
|
(17) |
|
|
|
|
|
Gelatt et al., 1977 |
Glaucomatous beagles |
Acepromazine ketamine |
|
|
0.09 0.04b |
|
|
(35) |
|
|
|
|
|
PeiVer et al., 1976 |
Glaucomatous beagles |
Sodium pentobarbital |
|
|
0.15 0.09b |
|
|
(35) |
|
|
|
|
|
|
|
Ketamine acetyl promazine |
|
|
|
|
|
|
|
|
|
|
|
Values are a range or means standard error or standard deviation as provided in the original papers. The articles are those reporting one or more values of aqueous humor dynamics in glaucomatous or healthy untreated or vehicle treated dogs.
C, outflow facility measured by atwo level constant pressure perfusion method, btonography; Fa, aqueous flow measured by fluorophotometry; IOP, intraocular pressure measured by pneumatonometry; Pev, episcleral venous pressure measured by force displacement method.
203
TABLE VI
Recent Studies of Aqueous Humor Dynamics in Monkeys
References |
Species |
IOP mmHg |
Fa (ml/min) |
C (ml/min/ mmHg) |
Fu (ml/min) |
||
|
|
|
|
|
|
|
|
Ocular normotensive monkeys |
|
|
|
|
|
|
|
Nilsson et al., 2006 |
Cynomolgus |
18 |
1 |
1.9 0.3 |
0.69 0.13a |
0.53 |
0.18e |
Okka, Tian and Kaufman, 2004 |
Cynomolgus |
19.3 |
0.8 |
|
0.51 0.08a |
|
|
|
|
18.8 |
0.7 |
1.8 0.2 |
|
|
|
Peterson et al., 2000b |
Cynomolgus |
16–17 |
|
|
|
||
Peterson et al., 2000a |
Cynomolgus |
|
|
2.0 0.2 |
Multiple studies with |
|
|
|
|
|
|
|
|||
|
|
|
|
|
results between |
|
|
|
|
|
|
|
a |
|
|
|
|
|
|
|
0.27 0.04a and |
|
|
|
|
|
|
|
0.59 0.12 |
|
|
Toris et al., 2006b |
Cynomolgus |
22.5 |
0.7 |
1.5 0.1 |
0.11 0.02b |
0.47 |
0.17f |
Gabelt et al., 2005 |
Cynomolgus |
14–16 |
2.0 0.3 |
0.90 0.26a |
0.48 |
0.13e |
|
|
|
|
|
|
0.40 0.06c |
|
|
Toris et al., 2005 |
Cynomolgus |
23.4 |
5.3 |
1.7 0.3 |
0.15 0.07b |
0.35 |
0.72f |
Tian and Kaufman, 2005 |
Cynomolgus and Rhesus |
|
|
|
0.36 0.04a |
|
|
Tian et al., 2004 |
Cynomolgus |
12–13 |
|
0.50 0.07a |
|
|
|
Takagi et al., 2004 |
Cynomolgus |
21–23 |
1.5 0.1 |
0.45 0.08a |
1.01 |
0.22f |
|
Gabelt et al., 2004 |
Cynomolgus |
15–18 |
1.4 0.3 |
0.26 0.02a |
0.32 |
0.12f |
|
|
|
|
|
|
0.27 0.04a |
|
|
Chien et al., 2003 |
Cynomolgus |
15–18 |
1.8 0.2 |
0.55 0.07d |
|
|
|
(Continued)
204
TABLE VI (Continued)
References |
Species |
IOP mmHg |
Fa (ml/min) |
C (ml/min/ mmHg) |
Fu (ml/min) |
||
|
|
|
|
|
|
|
|
Gabelt et al., 2001 |
Cynomolgus |
14.9 |
1.0 |
Multiple studies with |
0.35 0.05a |
|
|
|
|
|
|
results between |
|
|
|
|
|
16.0 |
1.7 |
1.4 0.18 and 2.1 0.1 |
0.50 0.09a |
|
|
|
|
|
|
|
|||
Toris et al., 2003 |
Cynomolgus |
22.3 |
3.6 |
1.7 0.3 |
0.15 0.09b |
0.35 |
0.92f |
Gabelt et al., 2003 |
Rhesus |
17.3 |
0.8 |
1.7 0.1 |
|
0.63 |
0.07g |
Toris et al., 2000 |
Cynomolgus |
22.2 |
2.4 |
1.5 0.6 |
0.16 0.14b |
0.14 |
1.20f |
Ocular hypertensive monkeys |
|
|
|
|
|
1.05 |
0.58e |
|
|
|
|
|
|
|
|
Nilsson et al., 2006 |
Cynomolgus |
30 |
4 |
2.1 0.3 |
0.08 0.04b |
|
0.28f |
Toris et al., 2006b |
Cynomolgus |
30.9 |
3.3 |
2.0 0.4 |
1.02 |
||
Toris et al., 2005 |
Cynomolgus |
35.1 |
13.6 |
1.8 0.6 |
0.09 0.08b |
0.37 |
1.00f |
Toris et al., 2003 |
Cynomolgus |
30.9 |
12.1 |
2.1 1.2 |
0.12 0.13b |
0.46 |
1.24f |
Toris et al., 2000 |
Cynomolgus |
33.8 |
8.0 |
1.9 0.9 |
0.06 0.04b |
0.92 |
0.65f |
Values are means standard error or standard deviation as provided in the original papers. The listed articles are those published within the past decade that reported one or more values of aqueous humor dynamics in untreated or vehicle treated ocular normotensive or hypertensive monkeys.
C, outflow facility measured by atwo level constant pressure perfusion method, bfluorophotometry, cflow to blood perfusion method, dtonography; Fa, aqueous flow measured by fluorophotometry; Fu, uveoscleral outflow measured by eintracameral tracer method, fmathematical calculation, gindirect isotope intracameral tracer method; IOP, intraocular pressure measured by tonometry.
